BUSINESS WIRE -- Onset Medical Corporation announced today the Company has received U.S. FDA 510(k) marketing clearance for new access applications of the Company’s SoloPathTM TransFemoral Endovascular Access Catheter. With this FDA marketing clearance, Onset believes that SoloPath now offers a complete line of products for access to the larger vascular anatomy with designs that provide a significantly superior method of accessing these larger vessels.
